FDA Approves New Human Insulin Product to Treat Diabetes

The short-acting insulin lispro injection has been granted final approval from the FDA to treat adults with type 2 diabetes and adults and children...
Source: Physician's First Watch current issue - Category: Primary Care Source Type: news